Intelligent Bio Solutions Inc.
INBS
$0.66
-$0.01-1.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.98M | -3.09M | -2.54M | -2.25M | -2.69M |
| Total Depreciation and Amortization | 303.40K | 306.20K | 296.80K | 307.60K | 303.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 409.70K | 269.80K | -900.00 | 56.00K | 73.70K |
| Change in Net Operating Assets | -576.90K | 304.20K | -507.80K | -438.90K | -78.40K |
| Cash from Operations | -2.85M | -2.21M | -2.76M | -2.32M | -2.39M |
| Capital Expenditure | -70.40K | -208.50K | -14.40K | -8.90K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -70.40K | -208.50K | -14.40K | -8.90K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.56M | 602.00K | 3.30M | 652.40K | 42.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 20.60K | -20.60K | -- |
| Cash from Financing | 3.56M | 602.00K | 3.32M | 631.70K | 42.50K |
| Foreign Exchange rate Adjustments | -700.00 | 29.30K | 13.10K | -45.30K | 30.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 640.20K | -1.79M | 564.90K | -1.75M | -2.31M |